Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03158389
Title NCT Neuro Master Match - N²M² (NOA-20) (N²M²)
Recruitment Recruiting
Gender
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University Hospital Heidelberg
Indications

IDH-wildtype glioblastoma

Therapies

Vismodegib

Alectinib

Idasanutlin

Temsirolimus

Atezolizumab

Palbociclib

APG101

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST